The document discusses equipment design, construction, cleaning, maintenance and repair for use in manufacturing pharmaceutical products. It emphasizes that equipment must be of appropriate design for its intended use and constructed of materials that will not react with or contaminate products. Cleaning and maintenance procedures must be established and validated to prevent contamination and ensure equipment functions properly. Equipment must undergo qualification testing before use and be cleaned and maintained regularly to guarantee product quality is not compromised.
Current good manufacturing practice .pptxOsamaTauseef2
Current good manufacturing practice according to Leon Lachman
Helpful contains for al pharmacy students like diploma, degree and also masters of pharmacy students
So use the contains and build your knowledge.
This document provides an overview of equipments and raw materials used in pharmaceutical manufacturing. It discusses the selection, purchase specifications, maintenance, and storage of both equipments and raw materials. Key points covered include cleaning and calibration of equipments, purchasing raw materials from approved vendors against specifications, and storing materials under proper conditions to prevent degradation.
This document discusses guidelines for equipment selection, purchase, specification, and maintenance in the pharmaceutical industry. It begins by defining equipment and its importance in pharmaceutical manufacturing. It then outlines the various stages of an equipment's lifecycle from the decision to purchase through maintenance and disposal. The document reviews guidelines from organizations like WHO, USFDA, MHRA, and others regarding factors to consider in equipment design, cleaning, identification, calibration, and record keeping. It emphasizes that equipment must be suitable for its intended use and not negatively impact product quality.
The document outlines good manufacturing practices (GMP) for nutraceuticals. It discusses 12 key areas that GMP for nutraceuticals covers: 1) Premises, 2) Equipment, 3) Personnel, 4) Quality Assurance, 5) Sanitation Program, 6) Operations, 7) Specifications, 8) Stability, 9) Samples, 10) Records, and 11) Recalls. Under each area, it provides details on requirements. For premises, it describes requirements for personnel and material flow, walls/ceilings, HVAC systems, utilities, and pest control. It emphasizes the need for preventative maintenance of equipment, calibration of instruments, and cleaning procedures. It also outlines personnel requirements for
This document provides an overview of GMP requirements for equipment used in pharmaceutical manufacturing. It discusses factors to consider when selecting equipment, as well as guidelines for equipment design, identification, cleaning, maintenance, and record keeping. The document outlines qualification processes like design, installation, operational, and performance qualification. It also covers specific equipment types like filters, balances, and automated or electronic devices. The goal is to help ensure equipment is suitable for its intended use and does not compromise product quality.
Current good manufacturing practice .pptxOsamaTauseef2
Current good manufacturing practice according to Leon Lachman
Helpful contains for al pharmacy students like diploma, degree and also masters of pharmacy students
So use the contains and build your knowledge.
This document provides an overview of equipments and raw materials used in pharmaceutical manufacturing. It discusses the selection, purchase specifications, maintenance, and storage of both equipments and raw materials. Key points covered include cleaning and calibration of equipments, purchasing raw materials from approved vendors against specifications, and storing materials under proper conditions to prevent degradation.
This document discusses guidelines for equipment selection, purchase, specification, and maintenance in the pharmaceutical industry. It begins by defining equipment and its importance in pharmaceutical manufacturing. It then outlines the various stages of an equipment's lifecycle from the decision to purchase through maintenance and disposal. The document reviews guidelines from organizations like WHO, USFDA, MHRA, and others regarding factors to consider in equipment design, cleaning, identification, calibration, and record keeping. It emphasizes that equipment must be suitable for its intended use and not negatively impact product quality.
The document outlines good manufacturing practices (GMP) for nutraceuticals. It discusses 12 key areas that GMP for nutraceuticals covers: 1) Premises, 2) Equipment, 3) Personnel, 4) Quality Assurance, 5) Sanitation Program, 6) Operations, 7) Specifications, 8) Stability, 9) Samples, 10) Records, and 11) Recalls. Under each area, it provides details on requirements. For premises, it describes requirements for personnel and material flow, walls/ceilings, HVAC systems, utilities, and pest control. It emphasizes the need for preventative maintenance of equipment, calibration of instruments, and cleaning procedures. It also outlines personnel requirements for
This document provides an overview of GMP requirements for equipment used in pharmaceutical manufacturing. It discusses factors to consider when selecting equipment, as well as guidelines for equipment design, identification, cleaning, maintenance, and record keeping. The document outlines qualification processes like design, installation, operational, and performance qualification. It also covers specific equipment types like filters, balances, and automated or electronic devices. The goal is to help ensure equipment is suitable for its intended use and does not compromise product quality.
Principles of GMP Training Module ProgramLucky Saggi
Good manufacturing practices (GMP) are regulations and guidelines for ensuring that products are consistently produced and controlled according to quality standards. GMP covers all aspects of production from facilities and equipment to processes and quality control. Following GMP procedures is important for guaranteeing high quality, safe products and compliance with regulations. Regular audits help ensure ongoing adherence to GMP standards.
pratik ghive cGMP According to schedule Mpratikghive82
Pratik Ghive Current Good Manufacturing Practices (cGMP) Guidelines According to schedule M Cover all guidelines as per Drug and cosmetic act 1940 and ICH guidelines
CGMP (Current Good Manufacturing Practices) ensures that medicinal products are consistently produced and controlled to quality standards required for their intended use. QA plays an important role in CGMP by verifying equipment qualifications, approving manufacturing documents, and verifying processes like cleaning validation, data integrity, sampling, and analytical reports. Maintaining CGMP requires following written procedures, accurately recording work, validating processes, developing facilities and equipment properly, maintaining quality control through practices like hygiene, and designing quality into manufacturing processes and product life cycles.
Quality control measures in pharmaceutical industryChemOnTheGo
QUALITY CONTROL
ROLE OF QUALITY CONTROL IN PHARMACEUTICAL INDUSTRY
OBJECTIVES OF QUALITY CONTROL
STEPS IN QUALITY CONTROL
COST OF QUALITY CONTROL
TOTAL QUALITY MANAGEMENT
QUALITY CIRCLE
The document discusses current good manufacturing practices (cGMP) regulations for pharmaceutical manufacturing. It covers several topics:
cGMP regulations provide systems for proper design, monitoring, and control of manufacturing to ensure identity, strength, quality and purity of drug products. Facilities must have adequate design and construction to prevent contamination. Equipment must be properly qualified, installed and maintained. Sanitation procedures help prevent contamination and ensure compliance. Overall, cGMP helps assure safety and efficacy of drug products.
This document provides information on current good manufacturing practices (CGMP) regulations enforced by the FDA to ensure quality in pharmaceutical manufacturing. It discusses the importance of CGMP for quality products, customer satisfaction, consistency and company reputation. The objectives are to understand regulatory requirements and minimize risks that can't be detected by final testing. The document outlines various CGMP guidelines related to facilities, equipment, personnel, documentation, batch records, quality control and more. It provides details on specific areas like premises, warehousing, water systems, waste disposal, production areas and equipment cleaning/validation.
This document provides an overview of current good manufacturing practice (cGMP) guidelines for active pharmaceutical ingredients (APIs) according to the US Food and Drug Administration (FDA). It discusses cGMP requirements for personnel responsibilities and training, facility design and maintenance, process utilities, containment practices, documentation and record keeping, and control of contamination during API manufacturing. The document is intended to provide guidance on complying with cGMP standards to ensure the quality of APIs.
QUALITY ASSURANCE OF PHARMACEUTICAL RELATED TO PLANT DESIGNsiddy-07
The document discusses quality assurance considerations related to plant design for pharmaceutical manufacturing. It covers topics like building construction, personnel flow, material flow patterns, effluent treatment, sterilization process control, temperature/humidity control via air handling units, air flow testing and validation of manufacturing equipment, water systems, and air handling units. Proper plant design is important to ensure consistent production of safe, effective pharmaceutical products and compliance with good manufacturing practices (GMP) regulations.
The document discusses current good manufacturing practices (cGMP) which are regulations for pharmaceutical manufacturers to ensure quality products. It covers several key points:
cGMP aim to ensure quality control throughout the manufacturing process from facilities and equipment to production, testing and documentation. Strict adherence to cGMP is important because testing alone cannot guarantee quality and consumers rely on manufacturers to consistently produce safe, effective drugs. The document outlines various cGMP requirements for organization and responsibilities, building facilities, equipment cleaning and maintenance, validation processes, standard operating procedures, and the overall objectives of producing products that meet specifications and quality standards.
documentation in pharmaceutical industry ppt.pptxashokgorja8
To define specifications and procedures for all materials and method of manufactured and control.
To ensure that all personal concern with manufacture know what to do and when to do it.
documentation in pharmaceutical industry ppt.pptxashokgorja8
The document discusses documentation requirements in the pharmaceutical industry. It defines documentation and explains that documentation is an integral part of good manufacturing practices (GMP). It describes the objectives of documentation such as defining specifications and procedures. It provides details about types of documentation required by GMP such as master formula records, batch manufacturing records, distribution records, specifications, and quality auditing. The document emphasizes that comprehensive documentation is necessary to ensure product quality and traceability in the pharmaceutical industry.
This document provides an overview of Good Manufacturing Practices (GMP) for pharmaceutical manufacturing. It defines GMP and explains that GMP aims to ensure consistent production of quality products through established processes and quality control. Key aspects of GMP covered include organization and personnel qualifications, facility and equipment design, material management, production operations, quality control testing, and documentation. Maintaining high standards of hygiene, sanitation, maintenance and training are emphasized. The goals of GMP are to minimize risks like contamination, incorrect dosing, and protect patient safety.
cGMp guidelines as per WHO ayansh singh.pptxAyanshSingh11
cGMP provides guidelines for pharmaceutical manufacturing and quality control. It aims to ensure products are consistently produced and meet quality standards. Key aspects of cGMP include having qualified personnel, adequate facilities and equipment, proper material management, quality management systems, validation of manufacturing processes, and documentation and record keeping. cGMP guidelines cover all stages of production from personnel and facilities to manufacturing, quality control testing, and maintenance of production records. Adherence to cGMP helps increase product quality and safety.
This document discusses the space requirements and considerations for designing a pharmaceutical pilot plant facility. It outlines that the facility should have separate areas for administration, physical testing, standard equipment, and storage. The standard equipment area should contain portable intermediate and full-scale production equipment for evaluating scale-up effects. The document also discusses raw material approval and validation, master batch records, analytical method transfer, product stability testing, and GMP compliance considerations like equipment qualification and validation.
PILOT PLANT SCALE- UP TECHNIQUE
Plant, Pilot Plant, Scale-up, Objective, Significance, Steps in scale up, General considerations, Master Manufacturing Procedures, GMP consideration.
I am uploading this GMP presentation to make aware who are working in pharma and help to maintain high standards in products manufacturing .
GMP Vs cGMP: It is my understanding that , Ultimately GMP & cGMP both the aim is same, means to prevention of the product from bad quality entering the market to endover peoples's life.
GMP applies to pharmaceutical and healthcare products and help to maintain high standards in these products.
cGMP is to remind accepting countries that all guidelines must be followed with latest and current production processes i.e employ technologies and systems which are up-to-date in order to comply with the regulation.
FDA (Food and Drug Administration) included the word “current” to ensure that regulated firms use the most current Good Manufacturing Practices (I believe that some firms would actually use outdated versions of the GMP’s to manufacture regulated products.
(the FDA have made their standards immediately identifiable i.e cGMP; Other international bodies such as the ICH, WHO use the term GMP, as do Canada, Japan and the EMEA (European authority). In FDA view cGMP means following 21 CFR 210 and 211 and no other.)
GMP regulations provide minimum standards for pharmaceutical manufacturing to ensure consistent high quality, safety, and efficacy of medicines. Key aspects of GMP include having documented procedures, validated processes, qualified facilities and equipment, trained personnel, cleaning and maintenance programs, quality control testing, and compliance auditing. Following GMP helps manufacturers produce pharmaceuticals that meet marketing authorizations and protects public health.
cGMP aims to ensure consistent production and control of quality standards for intended drug use and legal requirements. The 5 P's of cGMP are People, Products, Processes, Procedures, and Premises. cGMP principles include designing and constructing facilities properly, following written procedures and instructions, documenting work, validating processes, monitoring equipment, and conducting audits. cGMP regulations cover organization and personnel, facilities, equipment, production controls, packaging and labeling, laboratory testing, and record keeping. Key requirements include personnel training, sanitary facilities and practices, adequate ventilation and utilities, and cleaning and maintenance of equipment.
The document discusses Good Manufacturing Practices (GMP) for pharmaceutical manufacturing. It outlines requirements for facilities, equipment, personnel, documentation, production processes, quality control, and other operational aspects to minimize risks and ensure consistent production of quality products. GMP covers all aspects of production and testing to maintain standards, prevent contamination and errors, and comply with regulatory guidelines.
Good manufacturing practices (GMP) regulations ensure consistency and quality in pharmaceutical manufacturing. GMP covers facilities, equipment, personnel, production, packaging and quality control. Key requirements include designated clean areas for operations, qualified personnel, documented procedures, process validation, environmental monitoring, component testing and record keeping. GMP aims to prevent contamination and errors through strict quality standards at all stages of production.
Generating privacy-protected synthetic data using Secludy and MilvusZilliz
During this demo, the founders of Secludy will demonstrate how their system utilizes Milvus to store and manipulate embeddings for generating privacy-protected synthetic data. Their approach not only maintains the confidentiality of the original data but also enhances the utility and scalability of LLMs under privacy constraints. Attendees, including machine learning engineers, data scientists, and data managers, will witness first-hand how Secludy's integration with Milvus empowers organizations to harness the power of LLMs securely and efficiently.
In his public lecture, Christian Timmerer provides insights into the fascinating history of video streaming, starting from its humble beginnings before YouTube to the groundbreaking technologies that now dominate platforms like Netflix and ORF ON. Timmerer also presents provocative contributions of his own that have significantly influenced the industry. He concludes by looking at future challenges and invites the audience to join in a discussion.
More Related Content
Similar to Quality Management System (QMS): Equipment
Principles of GMP Training Module ProgramLucky Saggi
Good manufacturing practices (GMP) are regulations and guidelines for ensuring that products are consistently produced and controlled according to quality standards. GMP covers all aspects of production from facilities and equipment to processes and quality control. Following GMP procedures is important for guaranteeing high quality, safe products and compliance with regulations. Regular audits help ensure ongoing adherence to GMP standards.
pratik ghive cGMP According to schedule Mpratikghive82
Pratik Ghive Current Good Manufacturing Practices (cGMP) Guidelines According to schedule M Cover all guidelines as per Drug and cosmetic act 1940 and ICH guidelines
CGMP (Current Good Manufacturing Practices) ensures that medicinal products are consistently produced and controlled to quality standards required for their intended use. QA plays an important role in CGMP by verifying equipment qualifications, approving manufacturing documents, and verifying processes like cleaning validation, data integrity, sampling, and analytical reports. Maintaining CGMP requires following written procedures, accurately recording work, validating processes, developing facilities and equipment properly, maintaining quality control through practices like hygiene, and designing quality into manufacturing processes and product life cycles.
Quality control measures in pharmaceutical industryChemOnTheGo
QUALITY CONTROL
ROLE OF QUALITY CONTROL IN PHARMACEUTICAL INDUSTRY
OBJECTIVES OF QUALITY CONTROL
STEPS IN QUALITY CONTROL
COST OF QUALITY CONTROL
TOTAL QUALITY MANAGEMENT
QUALITY CIRCLE
The document discusses current good manufacturing practices (cGMP) regulations for pharmaceutical manufacturing. It covers several topics:
cGMP regulations provide systems for proper design, monitoring, and control of manufacturing to ensure identity, strength, quality and purity of drug products. Facilities must have adequate design and construction to prevent contamination. Equipment must be properly qualified, installed and maintained. Sanitation procedures help prevent contamination and ensure compliance. Overall, cGMP helps assure safety and efficacy of drug products.
This document provides information on current good manufacturing practices (CGMP) regulations enforced by the FDA to ensure quality in pharmaceutical manufacturing. It discusses the importance of CGMP for quality products, customer satisfaction, consistency and company reputation. The objectives are to understand regulatory requirements and minimize risks that can't be detected by final testing. The document outlines various CGMP guidelines related to facilities, equipment, personnel, documentation, batch records, quality control and more. It provides details on specific areas like premises, warehousing, water systems, waste disposal, production areas and equipment cleaning/validation.
This document provides an overview of current good manufacturing practice (cGMP) guidelines for active pharmaceutical ingredients (APIs) according to the US Food and Drug Administration (FDA). It discusses cGMP requirements for personnel responsibilities and training, facility design and maintenance, process utilities, containment practices, documentation and record keeping, and control of contamination during API manufacturing. The document is intended to provide guidance on complying with cGMP standards to ensure the quality of APIs.
QUALITY ASSURANCE OF PHARMACEUTICAL RELATED TO PLANT DESIGNsiddy-07
The document discusses quality assurance considerations related to plant design for pharmaceutical manufacturing. It covers topics like building construction, personnel flow, material flow patterns, effluent treatment, sterilization process control, temperature/humidity control via air handling units, air flow testing and validation of manufacturing equipment, water systems, and air handling units. Proper plant design is important to ensure consistent production of safe, effective pharmaceutical products and compliance with good manufacturing practices (GMP) regulations.
The document discusses current good manufacturing practices (cGMP) which are regulations for pharmaceutical manufacturers to ensure quality products. It covers several key points:
cGMP aim to ensure quality control throughout the manufacturing process from facilities and equipment to production, testing and documentation. Strict adherence to cGMP is important because testing alone cannot guarantee quality and consumers rely on manufacturers to consistently produce safe, effective drugs. The document outlines various cGMP requirements for organization and responsibilities, building facilities, equipment cleaning and maintenance, validation processes, standard operating procedures, and the overall objectives of producing products that meet specifications and quality standards.
documentation in pharmaceutical industry ppt.pptxashokgorja8
To define specifications and procedures for all materials and method of manufactured and control.
To ensure that all personal concern with manufacture know what to do and when to do it.
documentation in pharmaceutical industry ppt.pptxashokgorja8
The document discusses documentation requirements in the pharmaceutical industry. It defines documentation and explains that documentation is an integral part of good manufacturing practices (GMP). It describes the objectives of documentation such as defining specifications and procedures. It provides details about types of documentation required by GMP such as master formula records, batch manufacturing records, distribution records, specifications, and quality auditing. The document emphasizes that comprehensive documentation is necessary to ensure product quality and traceability in the pharmaceutical industry.
This document provides an overview of Good Manufacturing Practices (GMP) for pharmaceutical manufacturing. It defines GMP and explains that GMP aims to ensure consistent production of quality products through established processes and quality control. Key aspects of GMP covered include organization and personnel qualifications, facility and equipment design, material management, production operations, quality control testing, and documentation. Maintaining high standards of hygiene, sanitation, maintenance and training are emphasized. The goals of GMP are to minimize risks like contamination, incorrect dosing, and protect patient safety.
cGMp guidelines as per WHO ayansh singh.pptxAyanshSingh11
cGMP provides guidelines for pharmaceutical manufacturing and quality control. It aims to ensure products are consistently produced and meet quality standards. Key aspects of cGMP include having qualified personnel, adequate facilities and equipment, proper material management, quality management systems, validation of manufacturing processes, and documentation and record keeping. cGMP guidelines cover all stages of production from personnel and facilities to manufacturing, quality control testing, and maintenance of production records. Adherence to cGMP helps increase product quality and safety.
This document discusses the space requirements and considerations for designing a pharmaceutical pilot plant facility. It outlines that the facility should have separate areas for administration, physical testing, standard equipment, and storage. The standard equipment area should contain portable intermediate and full-scale production equipment for evaluating scale-up effects. The document also discusses raw material approval and validation, master batch records, analytical method transfer, product stability testing, and GMP compliance considerations like equipment qualification and validation.
PILOT PLANT SCALE- UP TECHNIQUE
Plant, Pilot Plant, Scale-up, Objective, Significance, Steps in scale up, General considerations, Master Manufacturing Procedures, GMP consideration.
I am uploading this GMP presentation to make aware who are working in pharma and help to maintain high standards in products manufacturing .
GMP Vs cGMP: It is my understanding that , Ultimately GMP & cGMP both the aim is same, means to prevention of the product from bad quality entering the market to endover peoples's life.
GMP applies to pharmaceutical and healthcare products and help to maintain high standards in these products.
cGMP is to remind accepting countries that all guidelines must be followed with latest and current production processes i.e employ technologies and systems which are up-to-date in order to comply with the regulation.
FDA (Food and Drug Administration) included the word “current” to ensure that regulated firms use the most current Good Manufacturing Practices (I believe that some firms would actually use outdated versions of the GMP’s to manufacture regulated products.
(the FDA have made their standards immediately identifiable i.e cGMP; Other international bodies such as the ICH, WHO use the term GMP, as do Canada, Japan and the EMEA (European authority). In FDA view cGMP means following 21 CFR 210 and 211 and no other.)
GMP regulations provide minimum standards for pharmaceutical manufacturing to ensure consistent high quality, safety, and efficacy of medicines. Key aspects of GMP include having documented procedures, validated processes, qualified facilities and equipment, trained personnel, cleaning and maintenance programs, quality control testing, and compliance auditing. Following GMP helps manufacturers produce pharmaceuticals that meet marketing authorizations and protects public health.
cGMP aims to ensure consistent production and control of quality standards for intended drug use and legal requirements. The 5 P's of cGMP are People, Products, Processes, Procedures, and Premises. cGMP principles include designing and constructing facilities properly, following written procedures and instructions, documenting work, validating processes, monitoring equipment, and conducting audits. cGMP regulations cover organization and personnel, facilities, equipment, production controls, packaging and labeling, laboratory testing, and record keeping. Key requirements include personnel training, sanitary facilities and practices, adequate ventilation and utilities, and cleaning and maintenance of equipment.
The document discusses Good Manufacturing Practices (GMP) for pharmaceutical manufacturing. It outlines requirements for facilities, equipment, personnel, documentation, production processes, quality control, and other operational aspects to minimize risks and ensure consistent production of quality products. GMP covers all aspects of production and testing to maintain standards, prevent contamination and errors, and comply with regulatory guidelines.
Good manufacturing practices (GMP) regulations ensure consistency and quality in pharmaceutical manufacturing. GMP covers facilities, equipment, personnel, production, packaging and quality control. Key requirements include designated clean areas for operations, qualified personnel, documented procedures, process validation, environmental monitoring, component testing and record keeping. GMP aims to prevent contamination and errors through strict quality standards at all stages of production.
Similar to Quality Management System (QMS): Equipment (20)
Generating privacy-protected synthetic data using Secludy and MilvusZilliz
During this demo, the founders of Secludy will demonstrate how their system utilizes Milvus to store and manipulate embeddings for generating privacy-protected synthetic data. Their approach not only maintains the confidentiality of the original data but also enhances the utility and scalability of LLMs under privacy constraints. Attendees, including machine learning engineers, data scientists, and data managers, will witness first-hand how Secludy's integration with Milvus empowers organizations to harness the power of LLMs securely and efficiently.
In his public lecture, Christian Timmerer provides insights into the fascinating history of video streaming, starting from its humble beginnings before YouTube to the groundbreaking technologies that now dominate platforms like Netflix and ORF ON. Timmerer also presents provocative contributions of his own that have significantly influenced the industry. He concludes by looking at future challenges and invites the audience to join in a discussion.
AI-Powered Food Delivery Transforming App Development in Saudi Arabia.pdfTechgropse Pvt.Ltd.
In this blog post, we'll delve into the intersection of AI and app development in Saudi Arabia, focusing on the food delivery sector. We'll explore how AI is revolutionizing the way Saudi consumers order food, how restaurants manage their operations, and how delivery partners navigate the bustling streets of cities like Riyadh, Jeddah, and Dammam. Through real-world case studies, we'll showcase how leading Saudi food delivery apps are leveraging AI to redefine convenience, personalization, and efficiency.
Have you ever been confused by the myriad of choices offered by AWS for hosting a website or an API?
Lambda, Elastic Beanstalk, Lightsail, Amplify, S3 (and more!) can each host websites + APIs. But which one should we choose?
Which one is cheapest? Which one is fastest? Which one will scale to meet our needs?
Join me in this session as we dive into each AWS hosting service to determine which one is best for your scenario and explain why!
Full-RAG: A modern architecture for hyper-personalizationZilliz
Mike Del Balso, CEO & Co-Founder at Tecton, presents "Full RAG," a novel approach to AI recommendation systems, aiming to push beyond the limitations of traditional models through a deep integration of contextual insights and real-time data, leveraging the Retrieval-Augmented Generation architecture. This talk will outline Full RAG's potential to significantly enhance personalization, address engineering challenges such as data management and model training, and introduce data enrichment with reranking as a key solution. Attendees will gain crucial insights into the importance of hyperpersonalization in AI, the capabilities of Full RAG for advanced personalization, and strategies for managing complex data integrations for deploying cutting-edge AI solutions.
Taking AI to the Next Level in Manufacturing.pdfssuserfac0301
Read Taking AI to the Next Level in Manufacturing to gain insights on AI adoption in the manufacturing industry, such as:
1. How quickly AI is being implemented in manufacturing.
2. Which barriers stand in the way of AI adoption.
3. How data quality and governance form the backbone of AI.
4. Organizational processes and structures that may inhibit effective AI adoption.
6. Ideas and approaches to help build your organization's AI strategy.
Things to Consider When Choosing a Website Developer for your Website | FODUUFODUU
Choosing the right website developer is crucial for your business. This article covers essential factors to consider, including experience, portfolio, technical skills, communication, pricing, reputation & reviews, cost and budget considerations and post-launch support. Make an informed decision to ensure your website meets your business goals.
Ocean lotus Threat actors project by John Sitima 2024 (1).pptxSitimaJohn
Ocean Lotus cyber threat actors represent a sophisticated, persistent, and politically motivated group that poses a significant risk to organizations and individuals in the Southeast Asian region. Their continuous evolution and adaptability underscore the need for robust cybersecurity measures and international cooperation to identify and mitigate the threats posed by such advanced persistent threat groups.
Building Production Ready Search Pipelines with Spark and MilvusZilliz
Spark is the widely used ETL tool for processing, indexing and ingesting data to serving stack for search. Milvus is the production-ready open-source vector database. In this talk we will show how to use Spark to process unstructured data to extract vector representations, and push the vectors to Milvus vector database for search serving.
Unlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdfMalak Abu Hammad
Discover how MongoDB Atlas and vector search technology can revolutionize your application's search capabilities. This comprehensive presentation covers:
* What is Vector Search?
* Importance and benefits of vector search
* Practical use cases across various industries
* Step-by-step implementation guide
* Live demos with code snippets
* Enhancing LLM capabilities with vector search
* Best practices and optimization strategies
Perfect for developers, AI enthusiasts, and tech leaders. Learn how to leverage MongoDB Atlas to deliver highly relevant, context-aware search results, transforming your data retrieval process. Stay ahead in tech innovation and maximize the potential of your applications.
#MongoDB #VectorSearch #AI #SemanticSearch #TechInnovation #DataScience #LLM #MachineLearning #SearchTechnology
HCL Notes and Domino License Cost Reduction in the World of DLAUpanagenda
Webinar Recording: https://www.panagenda.com/webinars/hcl-notes-and-domino-license-cost-reduction-in-the-world-of-dlau/
The introduction of DLAU and the CCB & CCX licensing model caused quite a stir in the HCL community. As a Notes and Domino customer, you may have faced challenges with unexpected user counts and license costs. You probably have questions on how this new licensing approach works and how to benefit from it. Most importantly, you likely have budget constraints and want to save money where possible. Don’t worry, we can help with all of this!
We’ll show you how to fix common misconfigurations that cause higher-than-expected user counts, and how to identify accounts which you can deactivate to save money. There are also frequent patterns that can cause unnecessary cost, like using a person document instead of a mail-in for shared mailboxes. We’ll provide examples and solutions for those as well. And naturally we’ll explain the new licensing model.
Join HCL Ambassador Marc Thomas in this webinar with a special guest appearance from Franz Walder. It will give you the tools and know-how to stay on top of what is going on with Domino licensing. You will be able lower your cost through an optimized configuration and keep it low going forward.
These topics will be covered
- Reducing license cost by finding and fixing misconfigurations and superfluous accounts
- How do CCB and CCX licenses really work?
- Understanding the DLAU tool and how to best utilize it
- Tips for common problem areas, like team mailboxes, functional/test users, etc
- Practical examples and best practices to implement right away
Threats to mobile devices are more prevalent and increasing in scope and complexity. Users of mobile devices desire to take full advantage of the features
available on those devices, but many of the features provide convenience and capability but sacrifice security. This best practices guide outlines steps the users can take to better protect personal devices and information.
UiPath Test Automation using UiPath Test Suite series, part 6DianaGray10
Welcome to UiPath Test Automation using UiPath Test Suite series part 6. In this session, we will cover Test Automation with generative AI and Open AI.
UiPath Test Automation with generative AI and Open AI webinar offers an in-depth exploration of leveraging cutting-edge technologies for test automation within the UiPath platform. Attendees will delve into the integration of generative AI, a test automation solution, with Open AI advanced natural language processing capabilities.
Throughout the session, participants will discover how this synergy empowers testers to automate repetitive tasks, enhance testing accuracy, and expedite the software testing life cycle. Topics covered include the seamless integration process, practical use cases, and the benefits of harnessing AI-driven automation for UiPath testing initiatives. By attending this webinar, testers, and automation professionals can gain valuable insights into harnessing the power of AI to optimize their test automation workflows within the UiPath ecosystem, ultimately driving efficiency and quality in software development processes.
What will you get from this session?
1. Insights into integrating generative AI.
2. Understanding how this integration enhances test automation within the UiPath platform
3. Practical demonstrations
4. Exploration of real-world use cases illustrating the benefits of AI-driven test automation for UiPath
Topics covered:
What is generative AI
Test Automation with generative AI and Open AI.
UiPath integration with generative AI
Speaker:
Deepak Rai, Automation Practice Lead, Boundaryless Group and UiPath MVP
Let's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with Slackshyamraj55
Discover the seamless integration of RPA (Robotic Process Automation), COMPOSER, and APM with AWS IDP enhanced with Slack notifications. Explore how these technologies converge to streamline workflows, optimize performance, and ensure secure access, all while leveraging the power of AWS IDP and real-time communication via Slack notifications.
Cosa hanno in comune un mattoncino Lego e la backdoor XZ?Speck&Tech
ABSTRACT: A prima vista, un mattoncino Lego e la backdoor XZ potrebbero avere in comune il fatto di essere entrambi blocchi di costruzione, o dipendenze di progetti creativi e software. La realtà è che un mattoncino Lego e il caso della backdoor XZ hanno molto di più di tutto ciò in comune.
Partecipate alla presentazione per immergervi in una storia di interoperabilità, standard e formati aperti, per poi discutere del ruolo importante che i contributori hanno in una comunità open source sostenibile.
BIO: Sostenitrice del software libero e dei formati standard e aperti. È stata un membro attivo dei progetti Fedora e openSUSE e ha co-fondato l'Associazione LibreItalia dove è stata coinvolta in diversi eventi, migrazioni e formazione relativi a LibreOffice. In precedenza ha lavorato a migrazioni e corsi di formazione su LibreOffice per diverse amministrazioni pubbliche e privati. Da gennaio 2020 lavora in SUSE come Software Release Engineer per Uyuni e SUSE Manager e quando non segue la sua passione per i computer e per Geeko coltiva la sua curiosità per l'astronomia (da cui deriva il suo nickname deneb_alpha).
How to Get CNIC Information System with Paksim Ga.pptxdanishmna97
Pakdata Cf is a groundbreaking system designed to streamline and facilitate access to CNIC information. This innovative platform leverages advanced technology to provide users with efficient and secure access to their CNIC details.
Unlocking Productivity: Leveraging the Potential of Copilot in Microsoft 365, a presentation by Christoforos Vlachos, Senior Solutions Manager – Modern Workplace, Uni Systems
1. Equipment
• Design of equipment for
intended purpose
• Repair and maintenance
operation
• Washing and cleaning
2. Design of equipment
for intended purpose
Equipment used in the manufacture,
processing, packing, or holding of a
drug product shall be of appropriate
design, adequate size, and suitably
located to facilitate operations for
its intended use and for its cleaning
and maintenance.
3. Equipment Design
• The effectiveness of equipment, like the quality of a product,
starts at the design stage.
• Most pharmaceutical companies are not directly involved
with the designs and construction of equipment but they can
contribute indirectly. They can, and do, provide information
on requirements and feedback on existing equipment. When
evaluating alternate types or makes of equipment, several
parameters need to be considered:
1. Operating criteria are adequate for the process—size, speed,
effectiveness (of, say, a mixer).
2. Availability of spares and servicing. This can result in using
different makes of equipment in different parts of the world.
4. Equipment Design
3. Maintenance. The frequency and ease of maintenance will significantly
impact on productivity and even quality. Equipment breakdown during
processing could adversely affect quality. Included in the maintenance
evaluation should be the cleanability of the equipment. This will involve
accessability to the parts needing to be cleaned and the relative ease of
disassembly and reassembly.
4. Environmental issues. Does the equipment disseminate dust, with the
potential for contaminating other products or making it necessary for
operators to wear additional protective clothing and facilities to be
cleaned more frequently? The possible impact of noise and energy use
and dissipation should be considered.
5. Construction materials and design.
5. Equipment Design
6. Availability of process controls such as automatic weight
adjustment on tablet presses and temperature recorders on
ovens. Although initially more expensive they could prove to
be very economic overall by providing more consistent
product quality and better records.
7. Cost. A comprehensive cost should, if possible, be compiled
which will include the base price plus any additional costs.
8. Availability of design and maintenance manuals from the
supplier that are important for validation/qualification and
maintenance programs
New equipment should not be used for commercial production until it
has been qualified and the process in which it is to be used has been
validated; this applies equally to laboratory and other test equipment
6. Equipment Construction
a) Equipment shall be constructed so that surfaces that contact components, in-process materials, or
drug products shall not be reactive, additive, or absorptive so as to alter the safety, identity,
strength, quality, or purity of the drug product beyond the official or other established
requirements.
(Compliance with this subsection requires the manufacturer to determine which drug products and
materials are to be processed in the equipment and where contact between materials and machinery
occurs. Since many of the surfaces of processing equipment are either stainless steel or glass this is
not too great a task. However, stainless steel is not totally inert and care should be exercised in
choosing the grade—note that distilled water is very corrosive and requires 316 grade, which should
then be passivated, usually with 15–30% nitric acid. Evaluation of potential interactions will include
introduction of unacceptable extractives from the equipment into the product, alteration of the
physical or chemical properties of the product, and introduction of particulates from abrasion of
surfaces).
7. Equipment Construction
(b) Any substances required for operation, such as lubricants or coolants, shall not come into contact
with components, drug product containers, closures, in-process materials, or drug products so as to
alter the safety, identity, strength, quality, or purity of the drug product beyond the official or other
established requirements.
(This requirement affects the design, construction, and placement of manufacturing equipment.
Motors, drive belts, gears, and other potential sources of lubricant contamination should be located
away from vessel or package openings that could result in product contamination. For equipment
where this is not possible, such as some mixers and tablet and encapsulating machines, lubrication
needs to be controlled and monitored; buildup of lubricant and powdered product should be regularly
removed and lubricants should be of food grade. Gaskets and other connecting surfaces should be
monitored to ensure they don’t break down, thereby allowing environmental contamination or gasket
particles into the product).
8. Equipment Cleaning And Maintenance
It is of interest to note that (a) identifies two reasons for cleaning, maintenance and
sanitation.
• First, to prevent contamination from materials previously utilizing the equipment.
• The second reason is an acknowledgment that inadequate cleaning or maintenance
may cause equipment to malfunction or break down and that this could have an
adverse effect on the process or product. For example, if a process required stirring
for 30 minutes at 60°C and the stirrer broke down, it is likely that the exposure to
heat could exceed 30 minutes by the time the stirrer was repaired or replaced.
The importance of the plant maintenance program is often underestimated with respect
to its potential impact on product quality. The main emphasis for maintenance programs
is to minimize the potential for breakdowns and to optimize production cycle times.
This emphasis is important. However, poor maintenance can also result in equipment
not functioning as intended, with consequent impact on processing and quality.
Inadequate maintenance can also enhance the potential for lubricant leakage, wear on
bearings and other equipment components, which could disgorge metal into the
product, and difficult-to-remove buildup of residues, which could later dislodge.
9. Repair and maintenance operation
• Balances and measuring equipment of an appropriate range and
precision should be available for production and control
operation.
• Weighing and testing equipment used in manufacture and quality
control should be calibrated, checked and properly recorded at
regular intervals and maintained properly to enable them to
perform their proper functions.
• Written procedures should be established and followed for
cleaning and maintenance of equipment, including utensils used
in the manufacture, processing, packing or holding of medicines
• Equipment should be checked for cleanliness prior to each use.
• Equipment used for the preparation of internal products should
be separated from that of external products.
10. Repair and maintenance operation
• Defective equipment should, if possible, be removed from production and quality control areas, or
at least be clearly labelled as defective.
• Repair and maintenance operations should not present hazard to the quality of the products.
• Production equipment should not present any hazard to the products. The parts of the production
equipment that come into contact with the product must not be reactive, additive or absorptive to
such an extent that it will affect the quality of the product and thus present any hazard.
• The equipment, filtering materials etc. used in the manufacturing processes must be compatible
with the extraction solvent, in order to prevent any release or undesirable absorption of substance
that could affect the product.
• Pipework and hoses for treated water and products should be cleaned and sanitised according to
written procedures.
11. Cleaning and sanitisation of equipment
• Equipment and utensils shall be cleaned, maintained, and sanitized at
appropriate intervals to prevent malfunctions or contamination that would
alter the safety, identity, strength, quality, or purity of the drug product
beyond the official or other established requirements
• Any missing components such as nuts, springs, clips, etc. should be
reported and investigated immediately.
• Vacuum or wet cleaning methods are preferred. Compressed air, fibrous
material and brushes should be used with care and avoided if possible, as
they increase the risk of product contamination.
• Adequate space, preferably separated from processing areas, should be
provided for cleaning and storing mobile equipment and the storage of
cleaning materials.
• Written procedures should be established and followed for cleaning and
sanitising equipments, utensils and containers used in the manufacture of
traditional medicines and health supplemen
12. Cleaning and sanitisation of equipment
• These procedures should be designed to prevent equipment contamination by cleaning or sanitising
agents and should at least include the following:
responsibility for cleaning.
cleaning schedule.
cleaning methods.
equipment and materials used in cleaning operations.
methods of disassembling and reassembling equipment.
removal of previous batch identification.
protection of clean equipment and utensils from contamination prior to use.
• Records of cleaning, where appropriate sanitising and inspection prior to use should be
maintained.
13. Cleaning Validation Program
• Equipment cleaning validation may be performed concurrently with actual production
steps during process development and manufacturing.
• Validation program should be continued through full scale commercial production.
• The concept “Test Until-Clean” should be applied. This concept involves cleaning,
sampling and testing with repetition of this sequence until an acceptable residue limit is
attained.
• A validation program generally encompasses at least three consecutive successful
replicate to establish that the procedure is reproducibly effective.
• If the equipment of the similar size, design and construction is cleaned by the same
procedure, studies need not be conducted on each unit as long as a total of three
successful replicates are done on similar piece of equipment; this concept is known as
equipment grouping.
14. Cleaning
Validation
Program
• Selection of cleaning Level (Type)
• Selection of cleaning method
• Selection of sampling method
• Selection of Scientific basis for the
contamination limit (acceptance criteria)
• Selection of Worst case related to the equipment
• Selection of Worst case related to the product
• Establishing the storage period after cleaning
(hold time study)
• Selection of analytical method
• Documentation
15. Selection Of Cleaning
Level (Type)
• TYPE A (MINOR)
This type of cleaning take place between two
batches of same product or between different
strengths of the same product. For minor cleaning,
cleaning validation is not required, since cross
contamination is not an issue.
• TYPE B (MAJOR)
This type of cleaning take place between two
products. In this case, validation of the
effectiveness of the cleaning procedure in
removing residues to the required level is
mandatory.
16. Selection of
Cleaning Method
• Manual cleaning
Difficult to validate.
Most extensive and elaborate cleaning procedures are required.
A high quality and extensive training program is required).
• Semi automatic or fully automatic cleaning systems
• Cleaning in place (CIP)
Cleaning of the equipment is performed in place without disassembling
Cleaning process may be controlled manually or by an automated program.
Very consistent and reproducible cleaning method.
Can be validated readily.
Being a closed system visual inspection of all components is difficult.
• Cleaning out of place (COP)
Cleaning of disassembled equipment is performed in a central washing
machine.
The washing machine also requires validation such as the temperature,
ultrasonic activity, cycle time, cleaning operation sequence, detergent
quantity dispensed etc.
17. Selection of sampling method
Generally there are two types of sampling that are accepted. The
most desirable is the direct method of sampling the surface of the
equipment, another method being the use of rinse sampling.
• Swab sampling (direct method)
It is also know as direct surface sampling method. This method is
based on the physical removal of residue left over on a piece of
equipment after it has been cleaned and dried. A swab wetted with a
solvent is rubbed over a previously determined sample surface area
to remove any potential residue, and thereafter extracted into a
known volume of solvent in which the contaminant active
ingredient residue is soluble. The amount of contaminant per swab
is then determined by an analytical method of adequate sensitivity.
• Rinse samples (indirect method)
This method is based on the analytical determination of a sample of
the last rinsing solvent (generally water) used in the cleaning
procedure. The volume of solvent used for the last rinse must be
known to allow for the quantitative determination of the
contamination.
18. Direct surface sampling (swab method)
Advantages
• Direct evaluation of surface contamination.
• Insoluble or poorly soluble substances may
be physically removed from the equipment
surfaces.
• Hard-to-clean but accessible areas are easily
incorporated into the final evaluation.
Disadvantages
• Difficult to implement in large-scale
manufacturing equipment.
• Extrapolation of results obtained for a small
sample surface area to the whole product
contact surface area.
Rinse samples (Indirect method)
Advantages
• Ease of sampling.
• Evaluation of entire product contact surface.
• Accessibility of all equipment parts to the
rinsing solvent.
• Best fitted to sealed or large scale equipment
and equipment which is not easily or
routinely disassembled.
Disadvantages
• No physical removal of the contaminant.
• The rinsing solvent may not reach
inaccessible or occluded part of equipment.
• Use of organic solvents for water insoluble
materials.
19. Selection of Scientific basis for the
contamination limit (acceptance criteria)
The rationale for selecting
limits for product residues
should be logically based on
a consideration of the
materials involved and their
therapeutic dose. The limit
should be practical,
achievable and verifiable.
20. Selection of Worst
Case Related to:
• The Equipment
Bracketing by equipment should be done only when it is
similar equipment, or the same equipment in different sizes
(e.g. 300-L, 500-L and 1000-L tanks). An alternative
approach may be to validate the smallest and the largest sizes
separately.
The worst case for a group of equipment is represented by the
equipment with the larger product contact surface and the
hardest-to-clean locations.
• The Product
Only one product out of a group of product processed in a
piece of equipment is selected for the cleaning validation
study, based on the lowest solubility of the active ingredient
and its therapeutic dose.
21. Establishing the Storage Period After
Cleaning (Hold Time Study)
• The objective for establishing time limit between
equipment cleaning and reuse is to ensure that the
equipment remains clean till the next use. This needs
demonstration that there is no microbial proliferation
in cleaned equipment's during storage.
• For establishing the time limit, the equipment should
be dried. Initial swab samples for surface should be
taken. Thereafter, the equipment should be protected
and stored in its designated area.
• Periodic samples of product contact surface for
microbiological contamination should be taken. (1st
day, 2nd day, 3rd day etc.)
• Based on the data generated establish the acceptable
time limit.
22. Selection of Analytical Method
There are many analytical techniques available that can be used in cleaning validation including:
• Specific Methods
Chromatographic methods such as GC, HPLC etc.
Thin layer chromatography.
Specific ion meter.
Of the above methods, chromatography methods are the methods of choice, as they separate analytes, are highly
specific, highly sensitive, and quantitative. But the methods are costly and time consuming.
• Non-specific Methods.
Spectrophotometric methods in the visible, infrared, or UV ranges
Total organic carbon (TOC)
Other Methods
For monitoring cleaning procedure TOC method is used. It offers at a moderate cost and in addition to its rapidity, a
detection capability down to the ppb range.
23. Documentation
• A Cleaning Validation Protocol is required to define how the cleaning process will be validated.
• Depending upon the complexity of the system and cleaning processes, the amount of documentation
necessary for executing various cleaning steps or procedures may vary.
• When more complex cleaning procedures are required, it is important to document the critical cleaning
steps.
• Other factors such as history of cleaning, residue levels found after cleaning, and variability of test
results may also dictate the amount of documentation required.
• A Final Validation Report should be prepared. The conclusions of this report should state if the
cleaning process has been validated successfully. Limitations that apply to the use of the validated
method should be defined
24. References
• Guidelines On Good Manufacturing Practice For Traditional Medicines And
Health Supplements.
• Good Manufacturing Practices for Pharmaceutical A Plan far Total Quality Control
from Manufacturer to Consomer Fifth Edition, Revised and Expended (Book).
• Goyal, D., Maurya, S., & Verma, C. (2016). Cleaning validation in pharmaceutical
industry-an overview. PharmaTutor, 4(9), 14-20.
• Raj, A. (2014). CLEANING VALIDATION IN PHARMACEUTICAL
INDUSTRIES. Journal of Atoms and Molecules, 4(4), 779.